High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

BACKGROUND: Limited data suggest that serious infections caused by Enterobacterales with a moderate to high risk of clinically significant AmpC production can be successfully treated with cefepime if the cefepime minimum inhibitory concentration (MIC) is ≤2 µg/mL. However, isolates with a cefepime-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz Coyne, Ashlan J, El Ghali, Amer, Lucas, Kristen, Witucki, Paige, Rebold, Nicholas, Holger, Dana J, Veve, Michael P, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034593/
https://www.ncbi.nlm.nih.gov/pubmed/36968970
http://dx.doi.org/10.1093/ofid/ofad034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034593/
https://www.ncbi.nlm.nih.gov/pubmed/36968970
http://dx.doi.org/10.1093/ofid/ofad034

Ejemplares similares